What is UBS's price target for QDEL?

UBS's latest stated price target for QuidelOrtho Corporation (QDEL) is $50, from its action on Sep 19, 2024.

What is UBS's rating on QDEL?

UBS rates QDEL Neutral, a neutral rating, as of Sep 19, 2024.

When did UBS last change its view on QDEL?

On Sep 19, 2024, UBS resumes coverage at Neutral, price target $42 to $50.

UBS QDEL price target and rating history

QuidelOrtho Corporation (QDEL) · Health Care

UBS rates QuidelOrtho Corporation (QDEL) Neutral with a $50 price target, as of its latest action on Sep 19, 2024. It has published 4 rating actions on QDEL since July 2022, including 1 upgrade and 1 downgrade.

Current rating: Neutral
Price target: $50
Median target, all firms: Too few
Actions on QDEL: 4

UBS price target on QDEL

UBS price target on QDEL, each point a stated target, July 2022 to September 2024.

Every UBS rating on QDEL

Sep 19, 2024
ResumeUBS resumes coverage at Neutral, price target $42 to $50
Mar 4, 2024
DowngradeUBS downgrades to Sell from Neutral, price target $70 to $42
Oct 14, 2022
UpgradeUBS upgrades to Neutral from Sell, price target $86
Jul 20, 2022
InitiateUBS starts coverage at Sell, price target $86

Questions about UBS and QDEL

What is UBS's price target for QDEL?: UBS's latest stated price target for QuidelOrtho Corporation (QDEL) is $50, from its action on Sep 19, 2024.
What is UBS's rating on QDEL?: UBS rates QDEL Neutral, a neutral rating, as of Sep 19, 2024.
When did UBS last change its view on QDEL?: On Sep 19, 2024, UBS resumes coverage at Neutral, price target $42 to $50.

More QDEL rating histories

All UBS ratings QDEL news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.